Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

Abstract

It is generally accepted that there are three subtypes of opiate receptor: µ, δ and κ. The main endogenous ligands for the µ-and δ-sites are Met5-enkephalin, Leu5-enkephalin and β-endorphin, whereas the putative endogenous ligands for the κ-binding site were unknown until recent observations suggested that dynorphin1–13 might be a candidate. The most convincing evidence for this view has been presented by Goldstein and his colleagues who showed that dynorphin1–13 is a specific endogenous ligand for the κ-receptor and has a high potency and long duration of action1–13. We show here that the sequences Leu5-enkephalyl-Arg-Arg-Ile (dynorphin1–8) and, particularly, Leu5-enkephalyl-Arg-Arg-Ile-Arg (dynorphin1–9) are selective ligands for the κ-binding site. Whereas dynorphin1–13 and dynorphin1–17 are relatively resistant to the action of peptidase and have a long duration of action in vitro after wash-out, dynorphin1–8 and dynorphin1–9 are readily degraded by peptidases and their duration of action is much shorter. For this and other reasons, the possibility will have to be considered that dynorphin1–8 or dynorphin1–9 may be transmitters or modulators at the κ-binding site while dynorphin1–13 and dynorphin1–17 may act hormonally, that is, at a distance from the site of release.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Chavkin, C. & Goldstein, A. Nature 291, 591–593 (1981).

    Article  ADS  CAS  Google Scholar 

  2. Chavkin, C. & Goldstein, A. Proc. nam. Acad. Sci. U.S.A. 78, 6543–6547 (1981).

    Article  ADS  CAS  Google Scholar 

  3. Chavkin, C., James, I. F. & Goldstein, A. Science 215, 413–415 (1982).

    Article  ADS  CAS  Google Scholar 

  4. Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. Nature 267, 495–499 (1977).

    Article  ADS  CAS  Google Scholar 

  5. Gillan, M. G. C., Kosterlitz, H. W. & Magnan, J. Br. J. Pharmac. 72, 13–15 (1981).

    Article  CAS  Google Scholar 

  6. Oka, T. et al. Eur. J. Pharmac. 73, 235–236 (1980).

    Article  Google Scholar 

  7. Oka, T. et al. Eur. J. Pharmac. 77, 137–141 (1982).

    Article  CAS  Google Scholar 

  8. Magnan, J., Paterson, S. J., Tavani, A. & Kosterlitz, H. W. Naunyn-Schmiedebergs Archs Pharmac. 319, 197–205 (1982).

    Article  CAS  Google Scholar 

  9. Römer, D. et al. Life Sci. 27, 971–978 (1980).

    Article  Google Scholar 

  10. Minamino, N., Kangawa, K., Fukuda, A. & Matsuo, H. Biochem. biophys. Res. Commun. 95, 1475–1481 (1980).

    Article  CAS  Google Scholar 

  11. Seizinger, B. R., Höllt, V. & Herz, A. Biochem. biophys. Res. Commun. 102, 197–205 (1981).

    Article  CAS  Google Scholar 

  12. Goldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M. & Hood, L. Proc. natn. Acad. Sci. U.S.A. 78, 7219–7223 (1981).

    Article  ADS  CAS  Google Scholar 

  13. Tachibana, S., Araki, K., Ohya, S. & Yoshida, S. Nature 295, 339–340 (1982).

    Article  ADS  CAS  Google Scholar 

  14. Minamino, N., Kangawa, K., Chino, N., Sakakibara, S. & Matsuo, H. Biochem. biophys. Res. Commun. 99, 864–870 (1981).

    Article  CAS  Google Scholar 

  15. Kangawa, K., Minamino, N., Chino, N., Sakakibara, S. & Matsuo, H. Biochem. biophys. Res. Commun. 99, 871–878 (1981).

    Article  CAS  Google Scholar 

  16. Pfeiffer, A., Pasi, A., Mehraein, P. & Herz, A. Neuropeptides 2, 89–97 (1981).

    Article  CAS  Google Scholar 

  17. Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M. & Hood, L. Proc. natn. Acad. Sci. U.S.A. 76, 6666–6670 (1979).

    Article  ADS  CAS  Google Scholar 

  18. Kosterlitz, H. W., Paterson, S. J. & Robson, L. E. Br. J. Pharmac. 73, 939–949 (1981).

    Article  CAS  Google Scholar 

  19. Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert, P. E. J. Pharmac. exp. Ther. 197, 517–532 (1976).

    CAS  Google Scholar 

  20. Gilbert, P. E. & Martin, W. R. J. Pharmac. exp. Ther. 198, 66–82 (1976).

    CAS  Google Scholar 

  21. Villarreal, J. E. & Seevers, M. H. Bull. Probl. Drug Dependence 34, Addendum 7, 1040–1053 (1972).

    Google Scholar 

  22. Swain, H. H. & Seevers, M. H. Bull. Probl. Drug Dependence 36, Addendum 1168–1195 (1974).

    Google Scholar 

  23. Swain, H. H. & Seevers, M. H. Bull. Probl. Drug Dependence 38, Addendum 2, 768–787 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corbett, A., Paterson, S., McKnight, A. et al. Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor. Nature 299, 79–81 (1982). https://doi.org/10.1038/299079a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/299079a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing